Literature DB >> 10623607

Thrombospondin-1, a natural inhibitor of angiogenesis, is present in vitreous and aqueous humor and is modulated by hyperglycemia.

N Sheibani1, C M Sorenson, L A Cornelius, W A Frazier.   

Abstract

Negative regulators of angiogenesis play a major role in maintaining vascular homeostasis. Thrombospondin-1 (TSP1) is a natural inhibitor of angiogenesis. This report examines the presence of TSP1 in ocular samples and determines whether its production is altered in diabetes. Western blot analysis detected a 140 kDa antiangiogenic fragment of TSP1(gp140) in vitreous samples prepared from normal human and rat eyes. Intact TSP1 was detected in aqueous humor samples prepared from normal rat and bovine eyes. In contrast, TSP1 was virtually absent in vitreous and aqueous humor samples prepared from diabetic rat eyes. Furthermore, production of TSP1 by microvascular endothelial cells in culture was sensitive to high concentrations of glucose. Retinal blood vessels appeared nonuniform and dilated in diabetic animals when compared to control animals. These results demonstrate that TSP1 and its antiangiogenic fragment are present in aqueous humor and vitreous of normal rat eyes and are dramatically reduced in diabetes. Thus, TSP1 may play a role in ocular vascular homeostasis and its absence may contribute to vascular dysfunctions associated with diabetes. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10623607     DOI: 10.1006/bbrc.1999.1903

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  36 in total

1.  Inflammatory cytokine-specific alterations in retinal endothelial cell function.

Authors:  Tammy L Palenski; Christine M Sorenson; Nader Sheibani
Journal:  Microvasc Res       Date:  2013-06-24       Impact factor: 3.514

2.  Impaired expression of thrombospondin-1 in eyes with age related macular degeneration.

Authors:  K Uno; I A Bhutto; D S McLeod; C Merges; G A Lutty
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

3.  Reduction of endogenous angiogenesis inhibitors in Bruch's membrane of the submacular region in eyes with age-related macular degeneration.

Authors:  Imran A Bhutto; Koichi Uno; Carol Merges; Lei Zhang; D Scott McLeod; Gerard A Lutty
Journal:  Arch Ophthalmol       Date:  2008-05

4.  Isolation and characterization of goat retinal microvascular endothelial cells.

Authors:  Ravinarayanan Haribalaganesh; Elayappan Banumathi; Sardarpasha Sheikpranbabu; Venkataraman Deepak; Namagiri Sirishkumar; Sangiliyandi Gurunathan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-03-07       Impact factor: 2.416

Review 5.  Thrombospondin-1 in ocular surface health and disease.

Authors:  William Foulsham; Thomas H Dohlman; Sharad K Mittal; Yukako Taketani; Rohan Bir Singh; Sharmila Masli; Reza Dana
Journal:  Ocul Surf       Date:  2019-06-05       Impact factor: 5.033

6.  Thrombospondin-1-Based Antiangiogenic Therapy.

Authors:  Jennifer N Sims; Jack Lawler
Journal:  J Ocul Pharmacol Ther       Date:  2015-06-03       Impact factor: 2.671

7.  Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor.

Authors:  V Stellmach; S E Crawford; W Zhou; N Bouck
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-23       Impact factor: 11.205

Review 8.  Matricellular protein thrombospondins: influence on ocular angiogenesis, wound healing and immuneregulation.

Authors:  Sharmila Masli; Nader Sheibani; Claus Cursiefen; James Zieske
Journal:  Curr Eye Res       Date:  2014-02-21       Impact factor: 2.424

Review 9.  Current and emerging therapies for corneal neovascularization.

Authors:  Danial Roshandel; Medi Eslani; Alireza Baradaran-Rafii; Albert Y Cheung; Khaliq Kurji; Sayena Jabbehdari; Alejandra Maiz; Setareh Jalali; Ali R Djalilian; Edward J Holland
Journal:  Ocul Surf       Date:  2018-06-20       Impact factor: 5.033

10.  Mechanisms of immune privilege in the anterior segment of the eye: what we learn from corneal transplantation.

Authors:  Junko Hori
Journal:  J Ocul Biol Dis Infor       Date:  2008-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.